The CEO of Pfizer, a company that has boosted its price and the stock markets around the world with the announcement of advances in a vaccine against covid-19, sold shares worth 5.56 million dollars (4.73 million euros) the day the pharmaceutical company made this news public, last Monday.

As stated in the documentation of the Security Exchange Commission (SEC), the equivalent body to the National Securities Market Commission in the US, Albert Bourla got rid of

132,508 securities

at $ 41.94 each, the value reached on Monday .

In the previous session, on Friday, the share had remained at 36.40 euros.

But the day of the announcement the parks of the whole world took a turn;

Pfizer claimed to have achieved 90% success with its vaccine project, an optimism with the tests against the coronavirus that was transmitted at high speed through the stock exchanges, with a special positive impact in Spain.

This Wednesday, before the publications in different media of this share transaction, the pharmaceutical company explained that the sale of Bourla shares does not correspond to a conjunctural movement, but to

a previously planned plan

.

"The sale of these shares is part of Bourla's financing plan," the company said.

The agreement therefore stipulated the placement of "a predetermined number of shares at a predetermined time".

The manager has lost

62% of his package

in the company.

With Pfizer's best listing since the summer, which was reached last Monday, the sale went through.

The moment of the transaction was thus the announcement of the advances with the vaccine.

The operation has

cost Bourla 5,557,385 dollars

, who would have received 4,823,291 if the company's price had not changed with respect to the previous trading session, on Friday.

The difference from one day to the next is estimated at 734,094 dollars, 624,203 euros

.

"Through our share plan administrator, Dr. Bourla

authorized the sale of these shares on August 19

, 2020, provided that the share was guaranteed to be at least a certain price," Pfizer explained.

The pharmaceutical company assured that Bourla has always followed rule 10b5-1 (b), which makes this type of exchange possible if the person carrying out the transaction shows that they

had

already

decided to carry it out before obtaining privileged information

.

According to Bourla in an interview with CNN, he did not learn until Sunday of the encouraging results of Pfizer's work on the virus.

Pfizer appreciated on Monday around 8%, a price improvement of about 20,000 million dollars, about 17,000 million euros.

For the Ibex 35, which led the globally generalized increases, that day was the best on parquet since May 2010.

According to the criteria of The Trust Project

Know more

  • Vaccinations

EmpresasChina suspends the debut of Grupo Ant, the largest exit in history

The Ibex closes the largest rise in 10 years driven by advances in the Covid vaccine

Markets The Ibex leads the rises in Europe and recovers 40% of the year's losses in two days

See links of interest

  • Last News

  • Programming

  • English translator

  • Work calendar

  • Movies TV

  • Topics

  • Netherlands - Spain, live